Skip to main content

2 Result(s)

within Daizhuang Peng Remove this filter

and

  1. Article

    Open Access

    Safety, tolerability, pharmacokinetics and effects of diet on AD16, a novel neuroinflammatory inhibitor for Alzheimer’s disease: a randomized phase 1 study

    AD16 is a Class 1.1 new drug candidate for Alzheimer’s disease (AD), which has demonstrated potential benefits in AD by reducing neuroinflammation in preclinical studies. Herein, the pharmacokinetics (PK), saf...

    Daizhuang Peng, Sumei Xu, Ting Zou, Yahui Wang, Wenjuan Ouyang, Yalan Zhang… in BMC Medicine (2023)

    Download PDF (1170 KB) View Article

  2. Article

    Open Access

    The prevention and treatment of COVID-19 in patients treated with hemodialysis

    Patients treated with hemodialysis are often immunocompromised due to concomitant disease. As a result, this population is at high risk of infection and mortality from COVID-19. In addition to symptomatic trea...

    Binyu Zeng, Jia Zhou, Daizhuang Peng, Chengmei Dong… in European Journal of Medical Research (2023)

    Download PDF (816 KB) View Article